tobramycin

FDA Drug Profile — TOBREX, BETHKIS, tobramycin

tobramycin is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand names including TOBREX, BETHKIS, tobramycin. Available dosage forms: ointment, solution, injection, powder, for solution.

Drug details

Generic Name
tobramycin
Brand Names
TOBREX, BETHKIS, tobramycin
Application Number
NDA050555
Sponsor
Novartis Pharmaceuticals Corporation
NDC Codes
4
Dosage Forms
OINTMENT, SOLUTION, INJECTION, POWDER, FOR SOLUTION
Routes
OPHTHALMIC, RESPIRATORY (INHALATION), INTRAVENOUS
Active Ingredients
TOBRAMYCIN

Indications and Usage

1 INDICATIONS AND USAGE Tobramycin inhalation solution is indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa . Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory volume in 1 second (FEV 1 ) <25% or >75% predicted, or patients colonized with Burkholderia cepacia [see Clinical Studies (14) ]. Tobramycin inhalation solution is an aminoglycoside antibacterial indicated for the management of cystic fibrosis in adults and pediatric patients 6 years of age and older with Pseudomonas aeruginosa. Safety and efficacy have not been demonstrated in patients under the age of 6 years, patients with forced expiratory volume in 1 second (FEV 1 ) <25% or >75% predicted, or patients colonized with Burkholderia cepacia .

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.